Brokerages Anticipate Prestige Consumer Healthcare Inc. (NYSE:PBH) Will Post Earnings of $1.10 Per Share

Wall Street analysts expect that Prestige Consumer Healthcare Inc. (NYSE:PBHGet Rating) will announce earnings per share (EPS) of $1.10 for the current fiscal quarter, according to Zacks Investment Research. Two analysts have provided estimates for Prestige Consumer Healthcare’s earnings, with the lowest EPS estimate coming in at $1.06 and the highest estimate coming in at $1.14. Prestige Consumer Healthcare posted earnings per share of $1.14 during the same quarter last year, which would indicate a negative year-over-year growth rate of 3.5%. The business is scheduled to report its next quarterly earnings report on Monday, January 1st.

On average, analysts expect that Prestige Consumer Healthcare will report full-year earnings of $4.27 per share for the current year, with EPS estimates ranging from $4.21 to $4.32. For the next financial year, analysts forecast that the company will post earnings of $4.47 per share, with EPS estimates ranging from $4.43 to $4.50. Zacks’ earnings per share averages are an average based on a survey of sell-side research analysts that follow Prestige Consumer Healthcare.

Prestige Consumer Healthcare (NYSE:PBHGet Rating) last announced its earnings results on Thursday, May 5th. The company reported $0.91 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.89 by $0.02. The business had revenue of $266.94 million during the quarter, compared to analysts’ expectations of $258.25 million. Prestige Consumer Healthcare had a net margin of 18.90% and a return on equity of 14.08%. The firm’s revenue for the quarter was up 12.3% on a year-over-year basis. During the same quarter last year, the company posted $0.79 EPS.

Several equities research analysts have weighed in on PBH shares. Oppenheimer upgraded shares of Prestige Consumer Healthcare from a “market perform” rating to an “outperform” rating and set a $63.00 price objective for the company in a research report on Monday. StockNews.com started coverage on shares of Prestige Consumer Healthcare in a research report on Thursday, March 31st. They issued a “buy” rating for the company. Three research analysts have rated the stock with a hold rating and two have given a buy rating to the company. Based on data from MarketBeat.com, Prestige Consumer Healthcare presently has an average rating of “Hold” and an average target price of $78.00.

Large investors have recently modified their holdings of the company. EverSource Wealth Advisors LLC acquired a new stake in shares of Prestige Consumer Healthcare during the 4th quarter worth approximately $26,000. Rockefeller Capital Management L.P. grew its position in shares of Prestige Consumer Healthcare by 54.4% during the 4th quarter. Rockefeller Capital Management L.P. now owns 843 shares of the company’s stock worth $51,000 after buying an additional 297 shares during the period. Point72 Hong Kong Ltd grew its position in shares of Prestige Consumer Healthcare by 1,705.4% during the 4th quarter. Point72 Hong Kong Ltd now owns 1,679 shares of the company’s stock worth $102,000 after buying an additional 1,586 shares during the period. Okabena Investment Services Inc. acquired a new stake in shares of Prestige Consumer Healthcare during the 4th quarter worth approximately $114,000. Finally, Islay Capital Management LLC acquired a new stake in shares of Prestige Consumer Healthcare during the 4th quarter worth approximately $129,000.

Shares of Prestige Consumer Healthcare stock traded up $2.88 during mid-day trading on Monday, reaching $57.76. 7,899 shares of the stock were exchanged, compared to its average volume of 271,543. The company has a market capitalization of $2.90 billion, a P/E ratio of 14.25, a price-to-earnings-growth ratio of 1.60 and a beta of 0.58. The company has a current ratio of 2.04, a quick ratio of 1.25 and a debt-to-equity ratio of 1.01. The company has a 50-day simple moving average of $54.79. Prestige Consumer Healthcare has a fifty-two week low of $45.93 and a fifty-two week high of $63.83.

Prestige Consumer Healthcare Company Profile (Get Rating)

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) healthcare products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.

Read More

Get a free copy of the Zacks research report on Prestige Consumer Healthcare (PBH)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Prestige Consumer Healthcare (NYSE:PBH)

Receive News & Ratings for Prestige Consumer Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prestige Consumer Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.